ZHANG XIN PING

·Personal Information

Current position: 英文主页 >Personal Information

Curriculum Vitae

Personal details

Name: Xinping Zhang

Position Title: Professor and Director.

Date of birth1964.02.27

Contact informationCenter for Pharmaceutical Policy Research of School of Health ManagementTongji Medical College, Huazhong University of Science and Technology.

Address: 13 Hangkong Road, Wuhan, Hubei province, 430030, P. R. China

Email: xpzhang602@163.comCell Phone: 86-27-8369-2332

 

Research interests

Key words:

rational medicine use, pharmaceutical policy, hospital management.

 

Personal statement: 

I have been engaged in the research of rational medicine use, pharmaceutical policy, hospital management and other aspects for many years. I have presided over and undertaken a number of national and provincial research projects which are innovative and forward-looking. For example, how to promote rational medicine use and improve medical service quality through transparency. The NNFS project “Research of regression model on regulatory transparency of essential medicines utilization in primary health care institutions” (No.71173082) was rated as excellent by the NNFS of China in 2018. And the research on community health service contract system won the science and technology progress award of Hubei province and Wuhan municipal people's government in 2006.

 

Education background and professional experience:

Educational experience:

1. Visiting ScholarHarvard UniversityAugust-October, 2012

2. PhDEpidemiology and Health StatisticsSchool of Medicine and Health Management, Tongji Medical CollegeHuazhong University of Science and Technology (HUST), China2001–2004;

3. MasterEpidemiology and Health StatisticsSchool of Public Health, Former Tongji Medical University, China

1988–1991;

4. BachelorPublic HealthDepartment of Health, Former Wuhan Medical College, China1981–1986

 

Professional experience:

1. ProfessorSchool of Medicine and Health ManagementTongji Medical CollegeHUST, China2005-now;

2. Associate ProfessorSchool of Medicine and Health ManagementTongji Medical CollegeHUST, China2000-2005;

3. LecturerDepartment of Management, Former Tongji Medical University, China1991-2000;

4. AssistantSchool of Public Health, Former Tongji Medical University, China1986-1988.

 

Selected publications

Books and Chapters:

1.         张新平刘兰茹药品管理学人民卫生出版社,2013.

2.         张新平,张俊超,黄金星基本药物制度监测评价研究科学出版社,2012.

3.         张新平,罗五金,何国忠中国药品监督管理体制研究湖南人民出版社,2006.

4.         张新平药品包装管理理论与实务中国医药科技出版社. 2006.

5.         张新平,陈连剑药事法学科学出版社,2004.

6.         张新平,李少丽药物政策学科学出版社,2003.

 

Positions and Honors

Start time

End time

Name of academic organization

Position

2017-12

2020-12

The   Professional Society for Health Economics and Outcomes Research ISPOR

Member   of the first pharmaceutical economics group, west China branch

2017-06

2020-06

China   Pharmaceutical Innovation and Research Development AssociationPhIRDA

Expert   of the medical policy council

 

2018-01

2019-12

Ideological   web articles evaluation system (iWaes)

evaluation   expert

 

Research Projects related to Pharmaceutical Policy Research:

No.

Title   of programs

Funding   agency

Period

Roles

Budget

10,000

1

Theorising pharmacist-patient communication   model and mechanism based on King’s Theory of Goal Attainment

NNFS

2018.01-2021.12

PI

48

2

Study of regulatory transparency mechanism   of medicine use based on transparency action cycle

NNFS

2014.01-2017.12

PI

56

3

Research of regression   model on regulatory transparency of essential medicines utilization in   primary health care institutions

NNFS

2012.01-2015.12

PI

42

4

Feasibility study of   implementing the National Essential Medicine System in village clinics and   non-government-run medical institutions

HB MOH

2011.05-2012.12


10

5

Study of compensation   mechanism of primary health sectors in the pilot areas of implementing the   National Essential Medicine System

HB MOH

2011.05-2012.12


10

6

Re-evaluation of post-marketing   Jian’ganle—an evidence-based research on selection and update of drug list

WKPL

2013.06-2013.12


10

7

Cooperative research on comparative   analysis of National Essential Drugs List2012and other lists of Hubei province

HB MOH

2013.03-2014.03


10

8

The   evidence-based research of development and selection of the list of medical   insurance and essential drugs—a case study of ShuXueTong injection

MYPL

2012.10-2013.10


10

9

Feasibility   research of using essential drugs in proportion in upper secondary hospitals

HB MOH

2012.05-2013.12


7

10

Strategies and effects of the essential   drug system implemented in primary health institutions

HB MOH

2012.05-2013.12


7

11

The investigation of use of essential   high-value medical consumables and feasibility research of their centralized   bid procurement

HB MOH

2012.05-2013.12


6

12

Equipment of the medicines in county-level   comprehensive hospital and comparatively analyzing these drugs with other   drug lists

MOH

2012.01-2012.12


4.1

13

A   retrospective study on primary development of national essential drug system   (2009~2011)

MOH

2012.01-2012.12


8

14

Research on effective   strategies of implementing the National Essential Medicine System in   community health service facilities

XJPL

2012.01-2012.12


13.3

15

Research of selecting the basic and high   value medical consumables

QH MOH

2012.01-2012.12


3.6

16

Performance evaluation of the new rural   cooperative medical system in Hubei province

HB MOH

2013.03-2014.03


3

17

Analyzing the medical expenses of four   diseases with four province’s data

CSIA

2013.06-2013.12


5

18

Research of improving the model of medical   assistance for impoverished population

Fudan University

2007.01-2007.03


5.25

19

Research of the modern hospital   prescription comment system in China

People's Hospital, Luoping

2010.06-2010.12


68

20

The comparison between basic medical   insurance directory and essential drug list

CHAC

2010.06-2010.11


8

21

Performance evaluation of the new rural   cooperative medical system’s outpatient co-ordination mode in Hubei Province

HB MOH

2009.12-2010.02


3

22

Research of basic drug policy in community   health service institutions

XJPL

2009.06-2010.05


22.5

23

Research on essential medicines policy

CPA

2009.05-2010.05


11

24

Research on international medicine policy   analysis

XJPL

2009.03-2009.06


4

25

Analysis and research on the current   situation of medicine management in community health service institutions

MOH

2008.07-2009.07


15

26

Research and development on the outline of training and   guidance for national medicine supervision personnel

CFDA

2008.03-2008.09


10

27

Performance evaluation of the new rural cooperative medical   system in Hubei Province from 2006 to 2007

HB MOH

2008.10-2008.12


3

28

Countermeasure research on the community-based   comprehensive management of orphans in high prevalence   areas of AIDS

CCDC

2008.03-2009.01


12

29

Evaluation of service   behavior of the appointed medical institutions   of new rural cooperative medical   system in Wuhan

Wuhan Health Bureau

2007.11-2008.04


3

30

Strategy research on implementing WHO Western Pacific   Region policy about improving the availability of essential medicines in   China

CFDA

2007.10-2008.04


1.5

31

Evaluation of rural network of medicine.

DRCRE CSC

2007.10-2008.09


4

32

Evaluation of operating mechanism &   effect of new rural cooperative medical in Hubei province.

HB MOH

2007.06-2008.05


4

33

Research on improving compensation level of   patients involved in new rural cooperative medical

HB MOH

2007.05-2008.05


2.5

34

Research on the new bidirectional referral   mechanisms of urban health service system.

Gongmin-g hospital, Shenzhen.

2007.01-2008.03


8

35

Mentoring program for division and   cooperation among community health services, preventive health care   institutions and hospitals.

MOH

2007.04-2007.11


15

36

Study of mentoring program for drugs of   community health services & mining of medical supplies.

MOH

2007.04-2007.11


15

37

Assessment program of new rural cooperative   medical services of designated medical institutions in Hubei province.

HB MOH

2007.01-2007.12


1

38

Benchmark study of iatrogenic infection   indicators measurement based on transparency

NNSF

2015.01-2018.12


62

* National Natural Science Foundation of China (NNSF); The State Food and Drug Administration (CFDA); Ministry of Health (MOH); Health Department of Hubei Province (HB MOH); The health department of Qinhai Province (QH MOH); Xian-Janssen Pharmaceutical Ltd (XJPL); Chinese Center For Disease Control And Prevention (CCDC); Development Research Center of Rural Economy of Chinese State Council (DRCRE CSC); Chinese Pharmaceutical Association (CPA); Community Health Association of China (CHAC); China Social Insurance Association (CHIA); Wuhan Kangle Pharmaceutical co., LTD (WKPL); Mudanjiang Youbo Pharmaceutical co., LTD (MYPL); 37* As the second person in charge, others is the first person in charge.


Peer-review papers (first author or corresponding author):

Rational medicine use and pharmaceutical policy:

1.         Zhang X, Cui Y, Liu C, Zuo K, Tang Y. Antibiotic Sales in Primary Care in Hubei Province, China: An Analysis of 2012-2017 Procurement Records. Int J Environ Res Public Health. 2019;16(18):3376. Published 2019 Sep 12. doi:10.3390/ijerph16183376

2.         Ye LP, Zhang XP. Visualizing the knowledge structure of medication-adherence research: A bibliometric analysis (1997-2016). International Journal of Health Planning and Management, 2019.

3.         Xiong Y, Cui Y, Zhang X. Pharmaceutical expenditure and total healthcare expenditure in OECD countries and China: bidirectional Granger causality on the basis of health level. Expert Review of Pharmacoeconomics & Outcomes Research. 2019; 1-8

4.         Chen H, Liu C, Liu J, Tang Y, Zhang X. Mixed effects of restriction strategies in antimicrobial stewardship programs on antimicrobial use in 121 tertiary hospitals in China. Expert Review of Pharmacoeconomics & Outcomes.2019;19(4):483-489.

5.         Tang Y, Liu C, Liu J, Zhang X, Zuo K. Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China. PharmacoEconomics. 2018.

6.         Tang Y, Liu C, Zhang Z, Zhang X. Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China. Cost Effectiveness and Resource Allocation. 2018;16.

7.         Tang Y, Liu C, Zhang X. Performance associated effect variations of public reporting in promoting antibiotic prescribing practice: a cluster randomized-controlled trial in primary healthcare settings. Primary Health Care Research and Development. 2017;18(5):482-91.

8.         Tang Y, Liu C, Zhang X. Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China. Applied Health Economics and Health Policy. 2017;15(1):57-64.

9.         Liu J, Wang L, Liu C, et al. Impact of price deregulation policy on the affordability of essential medicines for women’s health: a panel data analysis[J]. Expert review of pharmacoEconomics & outcomes research, 2017, 17(6): 625-631.

10.     Liu C, Zhang X, Liu C, Ewen M, Zhang Z, Liu G. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China. BMC Health Services Research. 2017 Aug 24;17(1):597.

11.     Liu, C., Zhang, X., Xuan, W., Zhang, X., Jie, W., & Zhong, F. Does public reporting influence antibiotic and injection prescribing to all patients? a cluster-randomized matched-pair trial in china. Medicine (Baltimore), 2016, 95(26), e3965.

12.     Tang Y, Liu C, Zhang X. Public reporting as a prescriptions quality improvement measure in primary care settings in China: variations in effects associated with diagnoses. Scientific Reports. 2016;6.

13.     Du X, Wang D, Wang X, Yang S, Zhang X*: Exploring the transparency mechanism and evaluating the effect of public reporting on prescription: a protocol for a cluster randomized controlled trial. BMC Public Health 2015, 15(1).

14.     Liu C, Zhang X*, Wan J: Public reporting influences antibiotic and injection prescription in primary care: a segmented regression analysis. J Eval Clin Pract 2015:n/a-n/a.

15.     Yang L, Liu C, Ferrier J A, et al. Organizational barriers associated with the implementation of national essential medicines policy: A cross-sectional study of township hospitals in China[J]. Social Science & Medicine. 2015, 145: 201-208.

16.     Wang D, Lai X, Liu C, et al. Influence of supplemental parenteral nutrition approach on nosocomial infection in pediatric intensive care unit of Emergency Department: a retrospective study. Nutrition Journal. 2015, 14(1).

17.     Yang L, Liu C, Wang L, Yin X and Zhang X* Public reporting improves antibiotic prescribing for upper respiratory tract infections in primary care: a matched-pair cluster-randomized trial in China. Health Research Policy and Systems, 2014,12:61.

18.     Zhang X, Wang L, Zhang X*. Application of propensity scores to explore the effect of public reporting of medicine use information on rational drug use in China: a quasi-experimental design. BMC Health Services Research, 2014,12:61.

19.     Wang X, Tang Y, Zhang X*. Effect of Publicly Reporting Performance Data of Medicine Use on Injection Use: A Quasi-Experimental Study. PloS one, 2014, 9(10): e109594.

20.     Tang YZhang XYang CYang L, Wang HZhang X*.  Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China. BMC Health Services Research. 2013,13:183. doi:10.1186/1472-6963-13-183.

21.     Yang L, Liu C, Ferrier JA, Zhou W, Zhang X*(Zhang Xinping). The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy and Planning, 2013;28(7):750-760.

22.     Zhang X, Xiong Y, Ye J, Deng Z, Zhang X*(Zhang Xinping). Analysis of government investment in primary healthcare institutions to promote equity during the three-year health reform program in China. BMC Health Serv Res. 2013-01-20 2013; 13:114.

23.     Tian XSong YZhang X, National Essential Medicines List and policy practice: A case study of China's health care reform, BMC Health Services Research 2012, 12:401.

24.     Xiang X, Yang C, Wang D, Ye J, Zhang X. Effects of China’s National Essential Medicines Policy on the Use of Injection in Primary Health Facilities. J Huazhong Univ Sci Technol, 2012,32(4) :626-629.

25.     Yang C, Yang L, Xiang X, Tang Y, Wang H, Nathan Bobai, Zhang X. Interventions Assessment of Prescription Automatic Screening System in Chinese Hospitals: A Systematic Review. Drug Information Journal. 2012, 46 (6): 669-676.

26.     Yang L, Zhang X*, Liu W and Wang H. Multifactor Analysis on the Income of Primary Health Care Institutions Implementing EMS in Hubei Province, China: A Cross-sectional Study. Journal of Health Management. 2012, 14(3): 259-268.

27.     Wang D, Zhang X* The selection of essential medicines in China: progress and the way forward. Southern Med, 2011, 4(1): 22-28.

28.     Yang H, Dib H H, Zhu M, Zhang X* et al. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Health policy and planning, 2010, 25(3): 219-229.

29.     Zhu M, Dib H H, Zhang X*, et al. The influence of health insurance towards accessing essential medicines: The experience from Shenzhen labor health insurance. Health policy, 2008, 88(2): 371-380.

 

Hospital management

30.     Xiong Y, Wang D, Chen H, Wang X, Zhang X. Development and Validation of Online Textual Pediatrician-Parent Communication Instrument Based on the SEGUE Framework. BioMed Research International. 2019; 1-8.  

31.     Liu J, Yin C, Liu C, Tang Y, Zhang X. Modeling a Production Function to Evaluate the Effect of Medical Staffing on Antimicrobial Stewardship Performance in China, 2009–2016: Static and Dynamic Panel Data Analyses. Frontiers in Pharmacology. 2018; 9:775.

32.     Wang X, Du X, Liu C, Zhang X. Does the professional attitude of physicians always affect their professional behaviour? A survey in tertiary hospitals in Nanchang City, China. Australian Health Review. Mar 2018.

33.     Wang D, Liu C, Zhang Z, Ye L, Zhang X. Validation of King's transaction process for healthcare provider-patient communication in pharmaceutical context: One cross-sectional study. Research in social & administrative pharmacy: RSAP. Mar 27 2018.

34.     Wang D, Liu C, Zhang Z, Ye L, Zhang X. Testing a healthcare provider-patient communicative relationship quality model of pharmaceutical care in hospitals. International journal of clinical pharmacy. Mar 31 2018.

35.     Ye L, Zhang X, Lai X. Does Hospital Ownership Influence Hand Hygiene Compliance?J Huazhong Univ Sci Technol,2017.1672-0733.

36.     Liu C, Tang Y, Wang D, Zhang X. The effect of public reporting presentation on patients' decision making: An experimental survey in Yunan Province, China. Medicine (Baltimore). 2017 Jun;96(24):e7203.

37.      Zhong F, Liu C, Zhang X. Guideline adherence for the treatment of advanced schistosomiasis japonica in Hubei, China. Parasitology research, 2014: 1-7.

38.     Zheng X, Zhong F, Zhang X. Doctors’ compliance with national guidelines and clinical pathway on the treatment of tuberculosis inpatients in Hubei, China. Journal of Evaluation in Clinical Practice. 2014, 20 (3):288-293.

39.     Shen Y, Li M, Zhang M*, Li Z, Wang L. Development and Influencing Factors of Compliance Behaviors of Investigators in Clinical Trials. J Huazhong Univ Sci Technol, 2014,34(2) :29-33.

40.     Zhang Q, Zhong F, Wu M, Zhang X*. Efficacy of Jian’ganle versus Hugan Pian, Glucuronolactone and Reduced Glutathione in Prevention of Antituberculosis Drug-induced Liver Injury* J Huazhong Univ Sci Technol, 2014,34(3) :29-34.

41.     Liu Q, Tian X, Tian J, Zhang X*(Zhang Xinping). Evaluation of the effects of comprehensive reform on primary healthcare institutions in Anhui Province. BMC Health Serv Res. 2014-01-20 2014; 14:268.

42.     Zhou W, Dong Y, Lin X, Lu W, Tian X, Zhang X*. Community health service capacity in China: a survey in three municipalities. Journal of Evaluation in Clinical Practice. 2011,19(1):167-172.

43.     Zhu M, Hassan H.Dib, Hu J, Tang S, Zhong T, Ming X, Zhang X*. Knowledge, awareness, behavior (KAB) and control of hypertension among urban elderly in Western China. International Journal of Cardiology.2009, 137 (1): 9–15.

44.     Zhang X*, Wang T. Quantitative analysis on economic contribution of community health service in China. J Huazhong Univ Sci Technolog Med Sci. 2004;24(1):103-106.

45.     Bärnighausen T, Liu Y, Zhang X, Sauerborn R. Willingness to pay for social health insurance among informal sector workers in Wuhan, China: a contingent valuation study. BMC Health Serv Res. 2007, 20;7:114.

 

Population aging and health

46.     Ye LP, Zhang XP. Social network types and health among older adults in rural China: the mediating role of social support. International Journal of Environmental Research and Public Health, 2019, 16(3): 410